Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Stock
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
7.62M
-
Shares change
-
-3.61M
-
Total reported value, excl. options
-
$4.95M
-
Value change
-
-$3.32M
-
Put/Call ratio
-
0
-
Number of buys
-
10
-
Number of sells
-
-23
-
Price
-
$0.65
Significant Holders of VYNE THERAPEUTICS INC COM - Stock (VYNE) as of Q1 2022
46 filings reported holding VYNE - VYNE THERAPEUTICS INC COM - Stock as of Q1 2022.
VYNE THERAPEUTICS INC COM - Stock (VYNE) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.62M shares
.
Largest 10 shareholders include DSC Advisors, L.P. (2.67M shares), VANGUARD GROUP INC (1.48M shares), RENAISSANCE TECHNOLOGIES LLC (965K shares), GEODE CAPITAL MANAGEMENT, LLC (470K shares), MILLENNIUM MANAGEMENT LLC (354K shares), GSA CAPITAL PARTNERS LLP (236K shares), STATE STREET CORP (204K shares), FRANKLIN RESOURCES INC (143K shares), BAILARD, INC. (139K shares), and Tekla Capital Management LLC (135K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.